nobiletin has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Q; Lei, S; Qiu, Z; Tian, L; Xia, ZY; Zhang, Y | 1 |
| Barg, S; Dibner, C; Gandasi, NR; Petrenko, V; Sage, D; Tengholm, A | 1 |
2 other study(ies) available for nobiletin and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Nobiletin alleviates myocardial ischemia-reperfusion injury via ferroptosis in rats with type-2 diabetes mellitus.
Topics: Animals; Diabetes Mellitus, Type 2; Ferroptosis; Flavones; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Reperfusion Injury | 2023 |
In pancreatic islets from type 2 diabetes patients, the dampened circadian oscillators lead to reduced insulin and glucagon exocytosis.
Topics: Adult; Animals; Circadian Rhythm; Diabetes Mellitus, Type 2; Exocytosis; Female; Flavones; Glucagon; Humans; In Vitro Techniques; Insulin; Islets of Langerhans; Male; Mice; Middle Aged; Young Adult | 2020 |